Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersSTU:1SP +4.20%59 EV-to-OCF is 29.40 as of Sep. 02, 2026, which is 7% below its 10-year median of 31.62. GuruFocus rates STU:1SP with a GF Score™ of 59/100 and a GF Value™ of €21.82 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Surgery Partners ranks worse than 85.96% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Surgery Partners's Enterprise Value is €6,501 Mil.
Surgery Partners's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €221 Mil. Therefore, Surgery Partners's EV-to-OCF for today is 29.40.
The historical rank and industry rank for Surgery Partners's EV-to-OCF or its related term are showing as below:
STU:1SP'
s EV-to-OCF Range Over the Past 10 Years
Min: 15.89 Med: 31.62 Max: 108.77
Current: 28.91
During the past 13 years, the highest EV-to-OCF of Surgery Partners was 108.77. The lowest was 15.89. And the median was 31.62.
STU:1SP's EV-to-OCF is ranked worse than 85.96% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 9.04
vs STU:1SP: 28.91
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Surgery Partners's PE Ratio (TTM) for today is calculated as:
Surgery Partners's share price for today is €12.40.
Surgery Partners's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.601.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Surgery Partners EV-to-OCF Related Terms
Surgery Partners EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Surgery Partners's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Surgery Partners's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Surgery Partners's EV-to-OCF falls into.
Surgery Partners's current Enterprise Value is €6,501 Mil.
Surgery Partners's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €221 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (STU:1SP) has a EV-to-OCF of 29.40 as of Sep. 02, 2026. This is near median its historical median of 31.62. Over the past decade, Surgery Partners' EV-to-OCF has ranged from 15.89 to 108.77. According to the industry distribution chart, Surgery Partners ranks #588 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 86%.
Is Surgery Partners' EV-to-OCF too high?
Surgery Partners' current EV-to-OCF of 29.40 is near median its 10-year median of 31.62. Over the past 10 years, this metric has ranged from a low of 15.89 to a high of 108.77. The Healthcare Providers & Services industry median EV-to-OCF is 9.04. Surgery Partners' value of 29.40 is 225.2% above this industry median. Based on the distribution chart, Surgery Partners ranks #588 out of 684 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Surgery Partners has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' EV-to-OCF compare to SNDA and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #588 out of 684 companies for EV-to-OCF. This places Surgery Partners in the lower half of its industry. The industry median EV-to-OCF is 9.04. Surgery Partners' value of 29.40 is 225.2% above this benchmark. Historically, Surgery Partners' own EV-to-OCF has ranged from 15.89 to 108.77 over the past decade. While the company's 10-year median is 31.62 vs. the industry median of 9.04, Surgery Partners has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 9.04, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current EV-to-OCF of 29.40 is 225.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 9.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current EV-to-OCF is 29.40, which is near median its own 10-year median of 31.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (STU:1SP) is currently considered Possible Value Trap. The stock's GF Value™ is €21.82, compared to a current price of €12.40 — trading 43.2% below its estimated fair value. The current EV-to-OCF is 29.40, which is near median its 10-year median of 31.62 and 225.2% above the Healthcare Providers & Services industry median of 9.04. Surgery Partners' overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Surgery Partners (STU:1SP), the current EV-to-OCF is 29.40 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (STU:1SP) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of €12.40 is trading 43.2% below its estimated GF Value™ of €21.82.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for STU:1SP:
EV-to-OCF: 29.40 (near median its 10-year median of 31.62)
GF Value™: €21.82 vs. price of €12.40 (43.2% below fair value)
Industry Position: 225.2% above the Healthcare Providers & Services median (#588 of 684)
No single metric tells the full story. See the STU:1SP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
59GF Score
Get the complete analysis for STU:1SP
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:1SP has been successfully added to your 
